| Date | Form | Description | Docs | XBRL | Pages |
| 09/14/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/29/98 | DEF 14A | Definitive proxy statements |
|
9 | |
| 06/15/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 03/17/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 01/29/98 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
40 | |
| 09/12/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
17 | |
| 06/23/97 | DEF 14A | Definitive proxy statements |
|
9 | |
| 06/13/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/09/97 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
10 | |
| 03/14/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
26 |
Latest News & Events
Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
Read More...Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
Read More...Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
Read More...